ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

3.87
Delayed Data
As of Feb 23
 +0.16 / +4.31%
Today’s Change
3.33
Today|||52-Week Range
7.88
-6.52%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for ZIOPHARM Oncology Inc have a median target of 9.50, with a high estimate of 23.00 and a low estimate of 5.00. The median estimate represents a +145.48% increase from the last price of 3.87.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in ZIOPHARM Oncology Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$1.6M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.54%
 
 
 
 
 
 
Growthannually 59.47%
 
 
 
 
 
 

Sales

Growthquarterly -0.44%
 
 
 
 
 
 
Growthannually -5.06%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.